TWST analyst estimates
Twist Bioscience (TWST) analyst ratings, the average price target and its range, and every firm's latest call.
TWST analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | Canaccord Genuity | Twist Bioscience price target raised to $205 from $120 at Canaccord | $205.00 |
| Oct 8, 2026 | Jefferies | Jefferies Starts Twist Bioscience (TWST) at Hold | $150.00 |
| Oct 7, 2026 | Barclays | Twist Bioscience price target raised to $215 from $112 at Barclays | $215.00 |
| Oct 1, 2026 | Guggenheim | Twist Bioscience price target raised to $212 from $107 at Guggenheim | $212.00 |
| Sep 29, 2026 | Leerink Partners | Twist Bioscience price target raised to $190 from $160 at Leerink | $190.00 |
| Sep 17, 2026 | Leerink Partners | Twist Bioscience price target raised to $160 from $120 at Leerink | $160.00 |
| Sep 9, 2026 | UBS | Twist Bioscience initiated with a Neutral at UBS | $144.00 |
| Aug 5, 2026 | Piper Sandler | Twist Bioscience price target raised to $115 from $85 at Piper Sandler | $115.00 |
| Aug 4, 2026 | Robert W. Baird | Twist Bioscience price target raised to $115 from $113 at Baird | $115.00 |
| Jul 16, 2026 | Leerink Partners | Twist Bioscience price target raised to $110 from $80 at Leerink | $110.00 |
| Jul 14, 2026 | Canaccord Genuity | Twist Bioscience price target raised to $120 from $90 at Canaccord | $120.00 |
| Jul 6, 2026 | Evercore ISI | Twist Bioscience downgraded to In Line from Outperform at Evercore ISI | $102.00 |
| Jun 29, 2026 | Guggenheim | Twist Bioscience price target raised to $107 from $60 at Guggenheim | $107.00 |
| Jun 24, 2026 | Barclays | Twist Bioscience price target raised to $95 from $65 at Barclays | $95.00 |
| Jun 15, 2026 | Cowen & Co. | Twist Bioscience price target raised to $89 from $68 at TD Cowen | $89.00 |
- 12 firms rate TWST: 8 buy, 3 hold, 1 sell.
- The average price target is $153.70 from 10 analysts, from $89.00 to $215.00.
Updated 2026-11-02 17:52 UTC